Seelos Therapeutics to Present at the 39th Annual Cowen Health Care Conference

NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. SEEL, a clinical-stage biopharmaceutical company, announced today that they will participate in the 39th Annual Cowen Health Care Conference. Chairman, Founder, and CEO Raj Mehra, PhD will present on Wednesday March 13th at 10:00am ET. Dr. Mehra's presentation will be followed by a breakout session beginning at 10:40am ET.

About Seelos Therapeutics:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company's robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:

Anthony Marciano

Head of Corporate Communications

Seelos Therapeutics, Inc.

anthony.marciano@seelostx.com

www.seelostherapeutics.com

Seelos_full logo and icon color.jpg

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsHealth CarePress ReleasesGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!